Gill Capital Partners’s BioVie BIVI Stock Holding History

Gill Capital Partners’s Portfolio BIVI Stock Details BIVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4	Hold	2	–	–	﹤0.01%	700
2026 Q1	$3	Buy	+2	New	+$3	﹤0.01%	699

Other funds holding BIVI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PTC

Philadelphia Trust Company Philadelphia, Pennsylvania $1.56B AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

PCM

Prelude Capital Management New York $1.37B AUM 71.68% 1-Year Est. Return

Gill Capital Partners's BIVI Position: Q2 2026 in Review

Gill Capital Partners held its BioVie (BIVI) position steady in Q2 2026 at 2 shares worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #700.

Gill Capital Partners first reported a position in BIVI in Q1 2026 and has held it in 2 quarters since. 36 funds tracked by Wall St. Rank hold BIVI as of Q2 2026.

Gill Capital Partners held 2 shares of BioVie worth $4 as of Q2 2026.
Gill Capital Partners left its BioVie share count unchanged in Q2 2026.
BioVie made up ﹤0.01% of Gill Capital Partners's portfolio in Q2 2026, its #700 holding.
Gill Capital Partners first reported a position in BioVie in Q1 2026 and has held it in 2 quarters since.
36 funds tracked by Wall St. Rank held BioVie as of Q2 2026.

Based on Gill Capital Partners's 13F filing for Q2 2026, filed 20 Aug 2026.